KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Equity Ratio (2016 - 2026)

AbbVie has reported Equity Ratio over the past 14 years, most recently at 0.02 for Q4 2025.

  • Quarterly Equity Ratio fell 197.95% to 0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02 through Dec 2025, down 197.95% year-over-year, with the annual reading at 0.02 for FY2025, 197.95% down from the prior year.
  • Equity Ratio was 0.02 for Q4 2025 at AbbVie, down from 0.02 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.12 in Q4 2022 and troughed at 0.02 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.09 (2021), against an average of 0.07.
  • Year-over-year, Equity Ratio surged 212.23% in 2021 and then tumbled 197.95% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.11 in 2021, then increased by 18.22% to 0.12 in 2022, then crashed by 38.03% to 0.08 in 2023, then plummeted by 68.13% to 0.02 in 2024, then tumbled by 197.95% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Equity Ratio are 0.02 (Q4 2025), 0.02 (Q3 2025), and 0.0 (Q2 2025).